+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Spain Veterinary Healthcare Market - Growth, Trends, and Forecasts (2020 - 2025)

  • ID: 5119865
  • Report
  • June 2020
  • Region: Spain
  • 111 Pages
  • Mordor Intelligence

FEATURED COMPANIES

  • Bayer Healthcare
  • Bioiberica S.A.U.
  • BioVet, SA
  • Ceva Animal Health Inc.
  • LABORATORIOS EURISKO
  • MSD Animal Health
Factors, such as pet owner’s willingness to provide veterinary care, supplements, and alternative treatment options, are improving the lives of pets. According to the Spanish Network for the Identification of Pets (REIAC), in 2018, there were 13 million registered pets in Spain and the numbers are observed to be rising. Out of 13 million registered pets, 93% were dogs, 6% cats, and the rest were mainly rabbits. Furthermore, the growing initiative taken by the government and non-government organizations regarding the vet health in Spain, increasing awareness among pet owners about animal health are also driving the market for the veterinary health market in Spain. According to FECAVA, in April 2018, Spain launched campaigns on the responsibility of pet ownership. The main objective of the action plan was to increase awareness about the responsibility of pet owners to care for their companion animals. However, lack of veterinarians and high cost associated with the veterinary healthcare practice are the major factors restraining the growth of veterinary healthcare market in Spain.

Key Market Trends

Anti-infectives to dominate the Spain Veterinary Healthcare Market

Anti-infectives are used for the prevention and treatment of infections in animals. There is a wide range of anti-infectives developed and manufactured by animal healthcare companies. Mainly, bacterial infection (pyoderma) in companion animals is caused by two organisms - Staphylococcus pseudintermedius and Staphylococcus schleiferi. Some of the anti-infectives available in the market studied are marbofloxacin (used as a single shot claim against respiratory disease and an E. coli mastitis claim in cattle), florfenicol (used against respiratory diseases), and freeze-dried ceftiofur (used as an injectable solution against respiratory diseases in cattle). Some of the suppliers of veterinary anti-infectives in Spain are Zoetis, Ceva Animal Healthcare, and Boehringer Ingelheim, among others. Zoetis offers products, such as Cydectin and Excede in the market. Increased bacterial infection in animals increases the need for anti-infective products for a healthy life of pets. However, antimicrobial resistance is a major concern threatening the effective prevention and treatment of infections caused by bacteria, parasites, viruses, and fungi. Thus, in order to prevent the growth of bacteria, fungi, or protozoa in the animals, the demand for anti-infective is expected to increase in Spain in the future.

Competitive Landscape

The Spain Veterinary Healthcare market displays high competition among market players. Major market players are investing high capitals on R&D and generating many strategies such as new product launches and developments, geographical expansions, collaborations and acquisitions to strengthen their market position in Spain Veterinary Healthcare market.

Reasons to Purchase this report:
  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support


This product will be delivered within 2 business days.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Bayer Healthcare
  • Bioiberica S.A.U.
  • BioVet, SA
  • Ceva Animal Health Inc.
  • LABORATORIOS EURISKO
  • MSD Animal Health

1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.1.1 Advanced Technology Leading to Innovations in Animal Healthcare
4.1.2 Increasing Pet Ownership
4.2 Market Restraints
4.2.1 Lack of Veterinarians and Shortage of Skilled Farm Workers
4.2.2 Increasing Cost of Animal Testing and Veterinary Services
4.3 Porter's Five Force Analysis
4.3.1 Threat of New Entrants
4.3.2 Bargaining Power of Buyers/Consumers
4.3.3 Bargaining Power of Suppliers
4.3.4 Threat of Substitute Products
4.3.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Product
5.1.1 By Therapeutics
5.1.1.1 Vaccines
5.1.1.2 Parasiticides
5.1.1.3 Anti-infectives
5.1.1.4 Medical Feed Additives
5.1.1.5 Other Therapeutics
5.1.2 By Diagnostics
5.1.2.1 Immunodiagnostic Tests
5.1.2.2 Molecular Diagnostics
5.1.2.3 Diagnostic Imaging
5.1.2.4 Clinical Chemistry
5.1.2.5 Other Diagnostics
5.2 By Animal Type
5.2.1 Dogs and Cats
5.2.2 Horses
5.2.3 Ruminants
5.2.4 Swine
5.2.5 Poultry
5.2.6 Other Animals
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Zoetis Inc.
6.1.2 MSD Animal Health
6.1.3 Bayer Healthcare
6.1.4 Ceva Animal Health Inc.
6.1.5 Boehringer Ingelheim International GmbH
6.1.6 S.P. Veterinaria
6.1.7 SUPER'S DIANA, S.L.
6.1.8 Bioiberica S.A.U.
6.1.9 LABORATORIOS EURISKO
6.1.10 BioVet, SA
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Zoetis Inc.
  • MSD Animal Health
  • Bayer Healthcare
  • Ceva Animal Health Inc.
  • Boehringer Ingelheim International GmbH
  • S.P. Veterinaria
  • SUPER'S DIANA, S.L.
  • Bioiberica S.A.U.
  • LABORATORIOS EURISKO
  • BioVet, SA
Note: Product cover images may vary from those shown

Loading
LOADING...